ClinicalTrials.Veeva

Menu

Gut Microbiota in Obesity and Diabetes

G

Gulhane School of Medicine

Status

Completed

Conditions

Type 2 Diabetes Mellitus
Obesity

Treatments

Other: Comparison of the gut microbiota composition

Study type

Observational

Funder types

Other

Identifiers

NCT02180191
GSM-2012/48
GSM-2012 (Other Identifier)

Details and patient eligibility

About

An altered gut microbiota composition has recently been linked to obesity and diabetes. The principal aim of this study was to investigate and compare the gut microbiota composition of obese, diabetic and control individuals. Then, associations between analyzed gut microbial concentrations and clinical-biochemical blood parameters were assessed.

Enrollment

81 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Subjects with obesity or newly diagnosed type 2 diabetes
  • 18 years to 65 years of age

Exclusion criteria

  • Any chronic disease (other than obesity and diabetes)
  • Alcohol consumption/smoking
  • Pregnancy/breastfeeding
  • The use of antibiotics, pro-prebiotics within 3 months
  • <18 years or >65 years
  • History of intestinal surgery

Trial design

81 participants in 3 patient groups

Obesity
Description:
27 obese individuals (20 men and 7 women with mean BMI: 39.98±5.56 kg/m2)
Treatment:
Other: Comparison of the gut microbiota composition
Diabetes
Description:
26 patients with newly diagnosed type 2 diabetes (18 men and 8 women with mean BMI: 28.63±5.08 kg/m2)
Treatment:
Other: Comparison of the gut microbiota composition
Control
Description:
Healthy control subjects (22 men and 6 women with mean BMI: 23.02±1.70 kg/m2)
Treatment:
Other: Comparison of the gut microbiota composition

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems